Skip to main content

Advertisement

Log in

Effects of a one-year administration of phosphate and intermittent calcitonin on bone-forming and bone-resorbing cells in involutional osteoporosis: A histomorphometric study

  • Clinical Investigations
  • Published:
Calcified Tissue International Aims and scope Submit manuscript

Summary

The bone histomorphometric effects of intermittent phosphate and calcitonin therapy during 1 year were analyzed in 15 involutional osteoporotic patients. Phosphate was administered continuously (1.5 g/day) and calcitonin was injected during 5 days every third week (50 IU/day). The bone cell response was analyzed in two separate groups, according to the amount of trabecular bone present in the iliac bone biopsy: patients with trabecular bone volume (TBV) beyond the histomorphometric spontaneous fracture threshold (0.16 mm3/mm3) (group 1; 11 patients) and patients with TBV above this threshold (group 2; 4 patients). In group 1, the treatment significantly increased TBV from 0.113±0.025 to 0.156±0.046 mm3/mm3 by thickening the existing trabeculae rather than by creating new trabeculae; stimulation of bone formation rate (+50%) and significant reduction in active trabecular resorption surfaces (from 0.021±0.013 to 0.010±0.006 mm2/mm2;P<.05) may have led to positive bone balance. In group 2, TBV was not changed because of the treatment's relative inefficiency for reducing the bone-resorbing cell activity, leading to likely persistent negative bone balance. Cortical thickness did not change in either group. This study confirms the positive effectiveness of continuous treatment with phosphate and intermittent calcitonin during 1 year on bone balance in involutional osteoporosis with low amount of bone. The lack of response in patients with normal amount of bone must be verified before raising the hypothesis of different bone cell activity and before anticipating the therapeutic response according to local bone mass besides bone remodeling status in osteoporosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Ringgs BL, Melton LJ, III (1986) Involutional osteoporosis. N Engl J Med 314:1676–1686

    Article  Google Scholar 

  2. Parfitt AM (1982) The coupling of bone formation to resorption: a critical analysis of the concept and its relevance to the pathogenesis of osteoporosis. Metab Bone Dis Rel Res 4:1–6

    Article  CAS  Google Scholar 

  3. Meunier PJ, Sellami S, Briancon D, Edouard C (1981) Histological heterogeneity of apparently idiopathic osteoporosis. In: De Luca HF (ed) Osteoporosis: recent advances in pathogenesis and treatment. University Park Press, Baltimore, pp 293–301

    Google Scholar 

  4. Riggs BL, Melton LJ, Wahner HW (1983) Heterogeneity of involutional osteoporosis: evidence for two distinct osteoporosis syndromes. In Frame B, Potts JT (eds) Clinical disorders of bone and mineral metabolism, Detroit, pp 337–342

  5. Parfitt AM, Mathews CHE, Villanueva AR (1983) Relationships between surface, volume, and thickness of iliac trabecular bone in aging and in osteoporosis. J Clin Invest 72:1396–1409

    PubMed  CAS  Google Scholar 

  6. Briancon D, Meunier PJ (1981) Treatment of osteoporosis with fluoride, calcium and vitamin D. Clin North Am 12:629–648

    CAS  Google Scholar 

  7. Slovik DM, Neer RM, Potts JF (1981) Short-term effects of synthetic human parathyroid hormone (1–34) administration on bone mineral metabolism in osteoporotic patients. J Clin Invest 68:1261–1271

    Article  PubMed  CAS  Google Scholar 

  8. Frost HM (1979) Treatment of osteoporosis by manipulation of coherent bone cell populations. Clin Orthop Rel Res 143:227–244

    Google Scholar 

  9. Rasmussen H, Bordier P, Marie P, Auquier L, Eisinger JB, Kuntz D, Caulin F, Argemi B, Gueris J, Julien A (1980) Effect of combined therapy with phosphate and calcitonin on bone volume in osteoporosis. Metab Bone Dis Rel Res 2:107–111

    Article  CAS  Google Scholar 

  10. Marie PJ, Caulin F (1986) Mechanisms underlying the effects of phosphate and calcitonin on bone histology in postmenopausal osteoporosis. Bone 7:17–22

    Article  PubMed  CAS  Google Scholar 

  11. Berthel M, Moyses B, Kuntzman F, Methlin G, Julien D, Caulin F (1984) Treatment of post-menopausal osteoporosis with phosphate and intermittent calcitonin: effect on cortical bone. In: Christiansen C and al. (eds) Osteoporosis. Glasturp Hosp, Copenhagen, pp 651–652

    Google Scholar 

  12. Goldsmith RS, Jowsey J, Dube WJ, Riggs BL, Arnaud CD, Kelley PJ (1976) Effects of phosphorus supplementation on serum parathyroid hormone and bone morphology in osteoporosis. J Clin Endocrinol Metab 43:523–532

    Article  PubMed  CAS  Google Scholar 

  13. Holtrop ME, Raisz LG, Simmons HA (1974) The effects of parathyroid hormone, colchicine and calcitonin on the ultrastructure and the activity of osteoclasts in organ culture. J Cell Biol 60:346–355

    Article  PubMed  CAS  Google Scholar 

  14. Chappard D, Alexandre C, Bousquet G, Riffat G (1983) Nouvelles modifications du trocart de Bordier pour la biopsie osseuse. Rev Rhum 50:307–308

    PubMed  CAS  Google Scholar 

  15. Chappard D, Alexandre C, Camps M, Montheard JP, Riffat G (1984) Embedding iliac bone biopsies at low temperature using glycol and methyl methacrylates. Stain Technol 58:299–308

    Google Scholar 

  16. Chappard D, Alexandre C, Riffat G (1983) Histochemical identification of osteoclasts in undecalcified human bone biopsies. Reappraisal of a simple procedure for routine diagnosis. Bas Appl Histochem 27:75–85

    CAS  Google Scholar 

  17. Courpron P, Lepine P, Arlot M, Lips P, Meunier PJ (1980) Mechanisms underlying the reduction with age of the mean wall thickness of trabecular basic structural units in human iliac bone. Metab Bone Dis Rel Res 25:323–329

    Google Scholar 

  18. Frost HM (1966) The bone dynamics in osteoporosis and osteomalacia. Charles C. Thomas (ed) Springfield

  19. Meunier P, Courpron P (1976) Iliac trabecular bone volume in 236 controls. Representativeness of iliac samples. In: Jaworski ZFG (ed) Bone morphometry. University of Ottawa Press, Ottawa, pp 100–105

    Google Scholar 

  20. Meunier P, Chavassieux P (1985) L'histomorphométrie: moyen d'évaluation de la masse osseuse. Rev Rhum 52:669–673

    PubMed  CAS  Google Scholar 

  21. Meunier P, Vignon G, Pansu D, Edouard C, Courpron P (1972) L'apport de la radiologie dans l'appréciation d'une déminéralisation rachidienne. Cah Med Lyon 48:4115–4122

    Google Scholar 

  22. Vost A (1963) Osteoporosis: a necropsic study of vertebral and iliac crests. Am J Pathol 43:143–151

    PubMed  CAS  Google Scholar 

  23. Frost HM (1985) The pathomechanics of osteoporoses. Clin Orthop Rel Res 200:198–225

    Google Scholar 

  24. Chavassieux PM, Arlot ME, Meunier PJ (1985) Intersample variation in bone histomorphometry: comparison between parameter values measured on two contiguous transiliac bone biopsies. Calcif Tissue Int 37:345–350

    PubMed  CAS  Google Scholar 

  25. Whyte MP, Bergfeld MA, Murphy WA, Avioli LV, Teitelbaum SL (1982) Post-menopausal osteoporosis. A heterogeneous disorder as assessed by histomorphometric analysis of iliac crest bone from untreated patients. Am J Med 72:193–202

    Article  PubMed  CAS  Google Scholar 

  26. Sainte Marie LG, Charhon SA, Meunier PJ (1983) Le test d'hypocalcémie à la calcitonine a-t-il une utilité dans les ostéoporoses? Presse Méd 12:2883–2884

    Google Scholar 

  27. Judy MM, Leconey TR, Matthews JL, Jee WSS (1980) Measurement of trabecular spacing and orientation by optical diffraction. In: Jee WSS, Parfitt AM (eds) Bone histomorphometry. Armour Montagu, Paris, pp 291–295

    Google Scholar 

  28. Mazess RB, Vetter J (1985) The influence of marrow on measurement of trabecular bone using computer tomography. Bone 6:349–351

    Article  PubMed  CAS  Google Scholar 

  29. Alexandre C, Chappard D (1986) Sequential use of phosphate and diphosphonate in the treatment of osteoporosis. Priliminary results. J Bone Min Res 1:S1–256.

    Article  Google Scholar 

  30. Harris WH, Heaney IA, Davis EH, Weinberg RD, Coutts RD, Shiller AL (1976) Stimulation of bone formation in vivo by phosphate supplementation. Calcif Tissue Int 22:85–98

    Article  CAS  Google Scholar 

  31. Toccafondi R, Zonefrati R, Galli G, Gennari C, Avioli LV (1986) Effect of L-lysine on growth and collagen synthesis in osteoblastlike cells. In: IXth Intl Conf on Calcium-Regulating Hormones and Bone Metabolism, October 25–November 1, 1986, Nice, France

  32. Gruber HE, Ivey JL, Baylink DJ, Matthews M, Nelp WB, Sisom K, Chesnut CH (1984) Long-term calcitonin therapy in post-menopausal osteoporosis. Metabolism 33:295–303

    Article  PubMed  CAS  Google Scholar 

  33. Aloia JF, Vaswani A, Meunier PJ, Edouard CM, Arlot ME, Yeh JK, Cohn SH (1987) Coherence treatment of postmenopausal osteoporosis with growth hormone and calcitonin. Calcif Tissue Int 40:253–259

    Article  PubMed  CAS  Google Scholar 

  34. Marie PJ, Rasmussen H, Kuntz D, Gueris J, Caulin F (1984) Treatment of postmenopausal osteoporosis with phosphate and intermittent calcitonin. In: Christiansen C (ed) Osteoporosis. Glostrup Hosp, Copenhagen, pp 575–580

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Alexandre, C., Chappard, D., Caulin, F. et al. Effects of a one-year administration of phosphate and intermittent calcitonin on bone-forming and bone-resorbing cells in involutional osteoporosis: A histomorphometric study. Calcif Tissue Int 42, 345–350 (1988). https://doi.org/10.1007/BF02556351

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02556351

Key words

Navigation